• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,164
2,283
1,851
1,828
1,712

COUNTRY

869
643
263
249
208

CATEGORIES

  • 856
  • 184
  • 950
  • 1,126
    • 99
  • 385
  • 270
  • 251
  • 65
  • 379
  • 673
  • 1,258
  • 1,621
  • 625
  • 883
  • 1,674
  • 2,639
    • 574
    • 118
    • 550
    • 75
    • 526
    • 43
    • 505
    • 18
    • 18
    • 23
  • 505
  • 726
  • 0
  • 97

PRICE

6,936
11,315
17,019
24,678

PUBLISHED

1,551
2,341
7,008
24,678

PRODUCT TYPE

20,304
3,174
856
164
74
44
21
21
13
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Metabolomics Market by Technique, Application & by Indication - Global Forecast to 2019

In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography Based on techniques, the metabolomics market is classified into Gas Chromatography,...

July 2014
FROM

Latest Guidebook for Conducting Pharma Clinical Trials in China: From Regulations to Practice (2014 Edition)

China is one of the fastest growing global economies with a fifth population in the world, and is one of the largest healthcare markets around the world Along with sustained economic and population...

July 2014
FROM

United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014

BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existing healthcare infrastructure. As the UAE is aiming to introduce comprehensive health insurance throughout...

July 2014

Denmark Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Like many other Western European countries, Denmark's expanding elderly population will ensure that demand for quality healthcare remains high and will be a key driving factor for its wellestablished, albeit...

July 2014

Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused...

July 2014

Malaysia Pharmaceuticals and Healthcare Report Q3 2014

BMI View: We remain generally optimistic towards Malaysia's commitment to provide better quality and access to healthcare, as the government plans to expand and upgrade its hospital network. However,...

July 2014

Portugal Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Faster-than-expected economic growth last quarter has led us to revise our healthcare and pharmaceutical forecasts slightly upwards. As forecast previously, BMI expects Portugal's healthcare...

July 2014

Iraq Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Thanks to the government's expansionary fiscal policy, spending on education, health and public services will increase. The Iraqi government has reportedly pledged to invest USD12bn into healthcare...

July 2014

South Africa Pharmaceuticals and Healthcare Report Q3 2014

BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market - boasting the largest medicines market on the continent and poised for high...

July 2014

Czech Republic Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales data from the first quarter. Price declines throughout Europe and restructuring of the healthcare system...

July 2014

Kuwait Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014, and the prospects for consumption remain bright. While price harmonisation across the GCC is likely...

July 2014

Qatar Pharmaceuticals and Healthcare Report Q3 2014

BMI View: Medicine prices are expected to decline shortly in Qatar amid the 'imminent' unification of medicine importation channels and the adoption of a new medicine pricing mechanism by the member...

July 2014

Global Infection Prevention and Control Market 2014-2018

About Infection Prevention and Control Infection prevention and control is the most important and significant step in the development and maintenance of products in the Medical Devices, Pharmaceuticals,...

July 2014
FROM

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2014

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2014 Summary This, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2014’, provides an overview of the Ankylosing...

July 2014
FROM

Endometrial Cancer - Pipeline Review, H2 2014

Endometrial Cancer - Pipeline Review, H2 2014 Summary This, ‘Endometrial Cancer - Pipeline Review, H2 2014’, provides an overview of the Endometrial Cancer’s therapeutic pipeline. This report provides...

July 2014
FROM

Hodgkin Lymphoma - Pipeline Review, H2 2014

Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary This, ‘Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides...

July 2014
FROM

Substance (Drug) Abuse - Pipeline Review, H2 2014

Substance (Drug) Abuse - Pipeline Review, H2 2014 Summary This, ‘Substance (Drug) Abuse - Pipeline Review, H2 2014’, provides an overview of the Substance (Drug) Abuse’s therapeutic pipeline. This...

July 2014
FROM

Smallpox - Pipeline Review, H2 2014

Smallpox - Pipeline Review, H2 2014 Summary This, ‘Smallpox - Pipeline Review, H2 2014’, provides an overview of the Smallpox’s therapeutic pipeline. This report provides comprehensive information...

July 2014
FROM

Brain Cancer - Pipeline Review, H2 2014

Brain Cancer - Pipeline Review, H2 2014 Summary This, ‘Brain Cancer - Pipeline Review, H2 2014’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014

Metastatic Pancreatic Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Pancreatic Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos